Welcome to the start of another year with Seminars in Thrombosis & Hemostasis (STH). This is my 5th year as Editor in Chief and my 8th year of editorial association with this journal, having previously served as a Regional Editor. This year we again celebrate with "some old and some new." Our current Senior Editors, Marcel Levi, Catherine P. M. Hayward, and Hau C. Kwaan, will continue in their existing roles as Senior Editors of this journal. Many of our Associate Editors are also staying on, but we have also received and accepted some resignations. Nobuo Sakuragawa from Japan has asked to be permitted to "retire" from his editorial duties, having served on the board for over a decade. Also leaving the board is Leo R. Zacharski, after nearly a decade on the board. Hideo Wada from Japan joined the board in mid-2012, in part, to take over editorial duties from Prof. Sakuragawa and he will continue in this role in 2013. Also relatively new to the board is Rüdiger E. Scharf, who also began his tenure in mid-2012, and, finally, Johannes Oldenburg, who begins his tenure in 2013 with this first issue. I sincerely thank both Nobuo Sakuragawa and Leo R. Zacharski for their past support for this journal and officially welcome Hideo Wada, Johannes Oldenburg, and Rüdiger E. Scharf to the STH board.
I also take this opportunity to thank Sangeeta PC, the Managing Editor for Thieme Medical Publishers, as well as her production team for their excellent editorial assistance, and Kelly Coffey, a Journals Coordinator for Thieme Medical Publishers, for additional support provided over the past year.
I think this is also a fitting time to reflect on our journal's Impact Factor, which for 2011 was 4.524 (►Fig. 1). This is the highest Impact Factor that STH has ever achieved. Notably, the ongoing positive trend also indicates that this journal continues to progress laudably. I have previously highlighted, 1, 2 and would continue to assert, that the Impact Factor is not the only marker of journal quality that we should consider, given the existence of other biometric markers and the limitations of any individual marker (including the Impact Factor) as an indicator of journal quality. Nevertheless, for those of you who may be interested, the top 52 listings of 2011-cited (2009/2010 published) contributions from this journal are provided in ►Table 1.
3-54 These contributions can therefore be identified as those most contributing to the 2011 Impact Factor, and each were cited four or more times in 2011. Notably, the top 11 articles on the list were cited between 10 and 23 times each in 2011, and the first two contributions were cited an impressive 20 or more times. A quick glance of the list will also indicate that the issue most contributing to this achievement was "Diagnostic Evaluation of Platelet Function Disorders," 55 guest edited by Catherine Hayward in 2009.
I therefore especially thank Catherine Hayward and all the contributors to this issue, as well as others highlighted in ►Table 1. Nevertheless, a big thank you also to all other contributors, guest editors, and the editorial team for bringing us the content that makes Seminars in Thrombosis & Hemostasis.
The current listing (►Table 1) can be compared with those of the most recently published top 50 downloaded article 
56,57
Finally, a short note to confirm that the editorial team will continue to develop plans for the future content of this journal, and we are confident that we will be able to continue to bring you, the reader, the high quality journal that you have come to expect in Seminars in Thrombosis & Hemostasis. Currently confirmed topics for issues that we plan to publish over the next 12 or so months are listed in ►Table 2. At the same time we recognize the need to retain some flexibility in our plans and to potentially add additional material of current interest and controversy as the need arises.
We look forward to another interesting year of reading in 2013! 
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